NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

计划入组 41 人 · 首次发布于 2003 年 2 月 6 日

Mood Disorders Bladder Cancer

计划入组 358 人 · 首次发布于 2019 年 7 月 30 日

Creative Arts Therapy (CAT) in the Center for Cancer and Blood Disorders

计划入组 83 人 · 首次发布于 2019 年 12 月 23 日

LGR4 modulators (cancer/bone disorders)

RNA modulator (Immune disorders/cancer)

next generation selective BET inhibitors (cancer/autoimmune disorders)

Institute For Neurodegenerative Disorders

United States

Ascendis Pharma Growth Disorders A/S

Denmark

The Center For Comprehensive Care and Diagnosis of Inherited Blood Disorders

United States

Bicara, Zenas, and MBX Bio Launch IPOs, Raising $703M for Clinical Trials

Apabetalone Shows Promise as Epigenetic Therapy for Chronic Diseases

EMA Recommends Approvals for Novel Therapies Targeting Cancer, Hemophilia, and Neurological Disorders